← Leaderboards
Felipe Medeiros
University Of California, San Diego
$9,200,810
Attributed
$12,802,060
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,802,060 · 9
By mechanism
R01$9,326,707 · 5
R42$1,692,924 · 1
P30$923,867 · 1
R21$858,562 · 2
Top collaborators
- C Ross Ethier5 shared
- W Daniel Stamer5 shared
- Sanjay Asrani4 shared
- Henry Tseng3 shared
- John Kar-Kin Zao3 shared
- Tzyy-Ping Jung2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Sally Liu Baxter$4,664,522
- Mark Christopher$2,023,152
- Shelley M Lawrence$2,876,915
- Sasan Moghimi Araghi$1,984,890
- Tsung-Ting Kuo$3,736,682
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaBlindnessVisionMeasurementResourcesBaseClinicOptical Coherence TomographyInnovationDiagnosisPerimetryCostClinical ResearchReportingCohortTrainingValidationPreventEvaluationScreeningClinical CareInvestigationImageLead
Grant awards (31)
Validation and Implementation of an Artificial Intelligence Machine-to-Machine (M2M) Model for Glaucoma Screening$521,555
R01 · FY2025 · EY · contact PI
Validation and Implementation of an Artificial Intelligence Machine-to-Machine (M2M) Model for Glaucoma Screening$628,531
R01 · FY2024 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$621,369
R01 · FY2022 · EY
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma$336,115
R01 · FY2022 · EY · contact PI
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma$208,063
R01 · FY2022 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$598,021
R01 · FY2021 · EY
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma$544,180
R01 · FY2021 · EY · contact PI
Objective Quantification of Neural Damage for Screening, Diagnosis and Monitoring of Glaucoma with Fundus Photographs$195,212
R21 · FY2021 · EY · contact PI
Transcriptional and Biomechanical Analysis of Segmental Outflow in Glaucoma$78,724
R01 · FY2021 · EY
OCT Measurement of Trabecular Meshwork Function In Vivo$76,362
R01 · FY2021 · EY
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma$561,010
R01 · FY2020 · EY · contact PI
OCT Measurement of Trabecular Meshwork Function In Vivo$493,667
R01 · FY2020 · EY
Objective Quantification of Neural Damage for Screening, Diagnosis and Monitoring of Glaucoma with Fundus Photographs$241,500
R21 · FY2020 · EY · contact PI
The nGoggle: A portable brain-based device for assessment of visual function deficits$648,557
R42 · FY2019 · EY
The BCI (Brain Computer Interface) Glaucoma Study: Objective Home-Based Detection of Progressive Visual Function Loss in Glaucoma$591,255
R01 · FY2019 · EY · contact PI
The nGoggle: A portable brain-based device for assessment of visual function deficits$195,000
R42 · FY2019 · EY
The nGoggle: A portable brain-based device for assessment of visual function deficits$849,367
R42 · FY2018 · EY
Development of a Portable Objective Method for Assessment of Visual Field Loss$193,750
R21 · FY2016 · EY · contact PI
Biostatistics$183,211
P30 · FY2016 · EY · contact PI
Biostatistics$11,635
P30 · FY2016 · EY · contact PI
Diagnostic Innovations in Glaucoma Study (DIGS): Functional Impairment$651,054
R01 · FY2015 · EY · contact PI
Development of a Portable Objective Method for Assessment of Visual Field Loss$228,100
R21 · FY2015 · EY · contact PI
Biostatistics$183,149
P30 · FY2015 · EY · contact PI
Diagnostic Innovations in Glaucoma Study (DIGS): Functional Impairment$653,434
R01 · FY2014 · EY · contact PI
Biostatistics$183,191
P30 · FY2014 · EY · contact PI
Diagnostic Innovations in Glaucoma Study (DIGS): Functional Impairment$635,666
R01 · FY2013 · EY · contact PI
Biostatistics$179,490
P30 · FY2013 · EY · contact PI
Diagnostic Innovations in Glaucoma Study (DIGS): Functional Impairment$728,125
R01 · FY2012 · EY · contact PI
Biostatistics$183,191
P30 · FY2012 · EY · contact PI
Diagnostic Innovations in Glaucoma Study (DIGS): Functional Impairment$754,058
R01 · FY2011 · EY · contact PI
Diagnostic Innovations in Glaucoma Study: Visual Function$645,518
R01 · FY2010 · EY · contact PI